MedPath

A Comparative Study for the Effectiveness of ''triple energizer treatment'' Method in Repairing Lung Injury in Patients with Novel coronavirus pneumonia (COVID-19)

Phase 1
Recruiting
Conditions
ovel Coronavirus Pneumonia (COVID-19)
Registration Number
ITMCTR2000003068
Lead Sponsor
Hubei Provincial Hospital Of TCM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients with Novel coronavirus pneumonia who are mainly admitted to hospitals in Hubei Province and whose temperature is normal for at least 5 days after treatment, whose vital signs are stable (including to be discharged) or who have been discharged, but whose lung damage has not improved.
1. Aged >=18 years male and female;
2. Clinically diagnosed and confirmed cases;
3. Classification: clinically diagnosed cases, confirmed cases of ordinary, severe, critical.

Exclusion Criteria

1. Other pneumonia;
2. Known to be allergic to traditional Chinese medicine ingredients, or patients with allergies;
3. Women during lactation and pregnancy, or have a positive urine pregnancy test.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TCM symptoms;Lung CT;
Secondary Outcome Measures
NameTimeMethod
Respiratory antibody combination;liver function;CRP;PCT;Renal function;Cytokine (IL-6);Blood routine;
© Copyright 2025. All Rights Reserved by MedPath